2-(4-Ethoxybenzyl)-1-isopentyl-N-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-benzo[d]imidazole-5-carboxamide

ID: ALA4588547

Chembl Id: CHEMBL4588547

PubChem CID: 155567324

Max Phase: Preclinical

Molecular Formula: C37H43N5O2

Molecular Weight: 589.78

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccc(Cc2nc3cc(C(=O)NCCNc4c5c(nc6ccccc46)CCCC5)ccc3n2CCC(C)C)cc1

Standard InChI:  InChI=1S/C37H43N5O2/c1-4-44-28-16-13-26(14-17-28)23-35-41-33-24-27(15-18-34(33)42(35)22-19-25(2)3)37(43)39-21-20-38-36-29-9-5-7-11-31(29)40-32-12-8-6-10-30(32)36/h5,7,9,11,13-18,24-25H,4,6,8,10,12,19-23H2,1-3H3,(H,38,40)(H,39,43)

Standard InChI Key:  UIKPRYUVBQFRSX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4588547

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Cholinesterases; ACHE & BCHE (1222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

N9 (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-22 (3261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 589.78Molecular Weight (Monoisotopic): 589.3417AlogP: 7.34#Rotatable Bonds: 12
Polar Surface Area: 81.07Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.89CX LogP: 7.08CX LogD: 5.75
Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.15Np Likeness Score: -1.30

References

1. Scheiner M, Dolles D, Gunesch S, Hoffmann M, Nabissi M, Marinelli O, Naldi M, Bartolini M, Petralla S, Poeta E, Monti B, Falkeis C, Vieth M, Hübner H, Gmeiner P, Maitra R, Maurice T, Decker M..  (2019)  Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo.,  62  (20): [PMID:31609608] [10.1021/acs.jmedchem.9b00623]

Source